Assessment of Depression and Anxiety in Patients with Fibromyalgia | ||
| Egyptian Journal of Psychiatry | ||
| Volume 45, Issue 2, May 2024, Pages 70-78 PDF (452.47 K) | ||
| DOI: 10.21608/EJPSY.2025.406239 | ||
| Authors | ||
| Dina M. Abd EL-Khalik* 1; Mohamed Eltohamy* 2 | ||
| 1Internal Medicine Department, Rheumatology Division, Faculty of Medicine, Ain Shams University, Cairo, Egypt. | ||
| 2Psychiatry Department, Armed Forces College Of Medicine, Cairo, Egypt | ||
| Abstract | ||
| Context Fibromyalgia syndrome (FMS) is a persistent pain, exhaustion, sleep disruption, and poor quality of life and daily performance disorder. Aims Examine depression and anxiety in fibromyalgia patients, as well as its relationship to illness severity. Settings and Design A case control study. Subjects and methods This case control research comprised ninety fibromyalgia patients and ninety healthy controls. Anxiety and depression were measured utilizing the Hospital Anxiety and Depression Scale (HADS). HADS were employed to evaluate depression and anxiety, which were clinically identified using Diagnostic and Statistical Manual Of Mental Disorders, 5th Edition (DSM-5) criteria. Results We found that older age, higher tender point count (TPC), higher symptom severity score, fibromyalgia impact questionnaire (FIQ), and unmarried patients were substantially associated with greater prevalence of depression among fibromyalgia patients. In terms of HADS anxiety and depression, we discovered a substantial variation between the groups. Conclusions Patients with FMS need mental assistance. Biological, psychological, and social techniques should all be used in treatment. | ||
| Keywords | ||
| Anxiety; Chronic pain; Depression; Fibromyalgia | ||
|
Statistics Article View: 57 PDF Download: 41 |
||
